ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Clomid for PCT, fertility or low T
Epigenetic Sperm Quality Test (SpermQT)
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 211081" data-attributes="member: 13851"><p><strong>Inherent Biosciences Launches Path Fertility - Epigenetic Sperm Quality Test (SpermQT)</strong></p><p><strong></strong></p><p><strong><em>*</em><u><em>SpermQT</em></u><em> analyzes the molecular function of sperm and is 6x more predictive of fertility potential than standard semen analysis</em></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>SALT LAKE CITY, Oct. 18, 2021 (GLOBE NEWSWIRE)</strong> -- <a href="https://www.globenewswire.com/Tracker?data=WECgy4RFAc-s_ACN8AdnN83u8odSKVxK1IzxLWw32oEdGhMABu_9ocmgxfMLk67JuXQYdAq86EU_0Niv5im7XTu2l5v71aQrtpWljFOfRAw=" target="_blank"><em>Inherent Biosciences</em></a><em>, a molecular diagnostics company at the intersection of epigenetics and artificial intelligence (AI), today announced the launch of <a href="https://www.globenewswire.com/Tracker?data=nK_ly5odiP0K-JFGP6QEjcUirX9vwAwbXv6TMOeAS3Hj3Up0mGl-CsY4STcC6uzYE5hREHS-5YFBv6KWiXlLIg==" target="_blank"><strong>Path Fertility's</strong></a><strong> Epigenetic Sperm Quality Test,</strong> SpermQTTM at the American Society for Reproductive Medicine Scientific Congress & Expo.</em></p><p></p><p><strong><em>"One in eight couples experience infertility and historically the focus of testing, treatment, and the burden has been on the female partner,"</em></strong><em> said Kristin Brogaard, Ph.D., co-founder and COO of Inherent Biosciences.<strong> "<u>50% of infertility is due to male factors and the standard semen analysis is a poor and rudimentary diagnostic test with only about 15% sensitivity</u>."</strong></em></p><p></p><p><strong><u><em>SpermQT</em></u> </strong><em><strong><em>a</em>nalyzes epigenetic patterns (DNA methylation) on genes associated with sperm production, sperm maturation, and embryo development. </strong>The test was validated with data from over 2,000 semen samples showing a sensitivity of 84% in predicting the need for In Vitro Fertilization (IVF) treatment. A detailed white paper describing the development and validation of SpermQT is available for download at <a href="https://www.globenewswire.com/Tracker?data=5ojv15bJkrf8Sn0CkO42xk1OWQInF4CizKJ7-ILj_Q7rh0-rm-GIlrVwrBVk0K466QomNzfMemd2aA9wDOd1nUmsNCLh_DQ3vffYwtEHe-w=" target="_blank">pathfertility.com</a>. A manuscript is in preparation for peer-reviewed publication.</em></p><p></p><p><strong><em>"There has been little innovation in semen analysis for decades," mentioned <u>Dr. Larry Lipshultz, internationally renowned urologist and clinical advisor to Inherent Biosciences</u>. "I'm most excited about epigenetics, and the data we're seeing for </em><u><em>SpermQT</em></u><em> shows tremendous promise."</em></strong></p><p><strong><em></em></strong></p><p><strong><em><u>SpermQT</u> is a physician-ordered test with an at-home specimen collection kit. Specimens are shipped to a CAP-accredited and CLIA certified laboratory for analysis. Results are reported as "High Risk" or "Low Risk" for poor sperm quality. The validation data showed that 84% of men with a "High Risk" result required IVF treatment. And, there was a statistically significant lower live birth rate when undergoing Intrauterine Insemination (IUI) treatment (p=0.025).</em></strong></p><p><strong><em></em></strong></p><p><strong><em>"We now have a diagnostic that significantly improves the measurement of sperm quality," </em></strong><em>said Alex Pastuszak, MD, Ph.D., Inherent Biosciences clinical advisor. "SpermQT provides reassurance for patients to move forward with natural or assisted conception."</em></p><p></p><p>For clinicians interested in offering <u>SpermQT</u> to patients, go to <a href="https://www.globenewswire.com/Tracker?data=5ojv15bJkrf8Sn0CkO42xi5i83I-TFnQ79EqAz8fECIzRY-OyBofIj6_0vX0y7Ch7dNkstSLKK8m-fHXbv9zCPOFm_AQgnmtuAMYVV1cwGhoR1it7xwC8x6nWQn3EXGD" target="_blank">pathfertility.com/providers</a> to request a copy of the white paper, an example report, and a test requisition form.</p></blockquote><p></p>
[QUOTE="madman, post: 211081, member: 13851"] [B]Inherent Biosciences Launches Path Fertility - Epigenetic Sperm Quality Test (SpermQT) [I]*[/I][U][I]SpermQT[/I][/U][I] analyzes the molecular function of sperm and is 6x more predictive of fertility potential than standard semen analysis[/I] SALT LAKE CITY, Oct. 18, 2021 (GLOBE NEWSWIRE)[/B] -- [URL='https://www.globenewswire.com/Tracker?data=WECgy4RFAc-s_ACN8AdnN83u8odSKVxK1IzxLWw32oEdGhMABu_9ocmgxfMLk67JuXQYdAq86EU_0Niv5im7XTu2l5v71aQrtpWljFOfRAw='][I]Inherent Biosciences[/I][/URL][I], a molecular diagnostics company at the intersection of epigenetics and artificial intelligence (AI), today announced the launch of [URL='https://www.globenewswire.com/Tracker?data=nK_ly5odiP0K-JFGP6QEjcUirX9vwAwbXv6TMOeAS3Hj3Up0mGl-CsY4STcC6uzYE5hREHS-5YFBv6KWiXlLIg=='][B]Path Fertility's[/B][/URL][B] Epigenetic Sperm Quality Test,[/B] SpermQTTM at the American Society for Reproductive Medicine Scientific Congress & Expo.[/I] [B][I]"One in eight couples experience infertility and historically the focus of testing, treatment, and the burden has been on the female partner,"[/I][/B][I] said Kristin Brogaard, Ph.D., co-founder and COO of Inherent Biosciences.[B] "[U]50% of infertility is due to male factors and the standard semen analysis is a poor and rudimentary diagnostic test with only about 15% sensitivity[/U]."[/B][/I] [B][U][I]SpermQT[/I][/U] [/B][I][B][I]a[/I]nalyzes epigenetic patterns (DNA methylation) on genes associated with sperm production, sperm maturation, and embryo development. [/B]The test was validated with data from over 2,000 semen samples showing a sensitivity of 84% in predicting the need for In Vitro Fertilization (IVF) treatment. A detailed white paper describing the development and validation of SpermQT is available for download at [URL='https://www.globenewswire.com/Tracker?data=5ojv15bJkrf8Sn0CkO42xk1OWQInF4CizKJ7-ILj_Q7rh0-rm-GIlrVwrBVk0K466QomNzfMemd2aA9wDOd1nUmsNCLh_DQ3vffYwtEHe-w=']pathfertility.com[/URL]. A manuscript is in preparation for peer-reviewed publication.[/I] [B][I]"There has been little innovation in semen analysis for decades," mentioned [U]Dr. Larry Lipshultz, internationally renowned urologist and clinical advisor to Inherent Biosciences[/U]. "I'm most excited about epigenetics, and the data we're seeing for [/I][U][I]SpermQT[/I][/U][I] shows tremendous promise." [U]SpermQT[/U] is a physician-ordered test with an at-home specimen collection kit. Specimens are shipped to a CAP-accredited and CLIA certified laboratory for analysis. Results are reported as "High Risk" or "Low Risk" for poor sperm quality. The validation data showed that 84% of men with a "High Risk" result required IVF treatment. And, there was a statistically significant lower live birth rate when undergoing Intrauterine Insemination (IUI) treatment (p=0.025). "We now have a diagnostic that significantly improves the measurement of sperm quality," [/I][/B][I]said Alex Pastuszak, MD, Ph.D., Inherent Biosciences clinical advisor. "SpermQT provides reassurance for patients to move forward with natural or assisted conception."[/I] For clinicians interested in offering [U]SpermQT[/U] to patients, go to [URL='https://www.globenewswire.com/Tracker?data=5ojv15bJkrf8Sn0CkO42xi5i83I-TFnQ79EqAz8fECIzRY-OyBofIj6_0vX0y7Ch7dNkstSLKK8m-fHXbv9zCPOFm_AQgnmtuAMYVV1cwGhoR1it7xwC8x6nWQn3EXGD']pathfertility.com/providers[/URL] to request a copy of the white paper, an example report, and a test requisition form. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Clomid for PCT, fertility or low T
Epigenetic Sperm Quality Test (SpermQT)
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top